FDA Approves Olumiant for Adolescents with Severe Alopecia Areata
FDA approves Olumiant (baricitinib) for patients aged 12 and older with severe…
New Access Strategy Announced for Investigational Monthly HIV Prevention Pill
Merck has announced an early access strategy for its investigational once-monthly HIV…
EU Approves First Oral GLP-1 Treatment for Weight Management
The European Commission has approved Wegovy® pill as the EU's first oral…
FDA Grants Priority Review for GSK’s Bepirovirsen for Chronic Hepatitis B
The FDA has granted Priority Review to GSK’s bepirovirsen for chronic hepatitis…
FDA accepts application for Roche’s Gazyva/Gazyvaro for the treatment of the most common form of lupus
The FDA has accepted Roche’s supplemental application for Gazyva/Gazyvaro as a treatment…
GSK completes acquisition of 35Pharma Inc.
GSK plc has completed the acquisition of 35Pharma Inc., adding HS235, a…
Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk
Eli Lilly and Company and Verve Therapeutics, Inc., a Boston-based clinical-stage company…
